Daewoong, Sygnature Discovery eyes autoimmune disease research
South Korea-based Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development.
Daewoong Pharmaceutical enters...
Humanigen announces positive interim Phase 3 Data of Lenzilumab in Covid patients
Humanigen Inc has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with Covid-19.
Humanigen is a clinical stage biopharmaceutical company focused on...
Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Research on preventative nasal spray reveals interesting results
Research on a 'novel' nasal spray therapy, INNA-051, which has been shown to reduce Covid-19 viral replication by up to 96 percent in a...
Freudenberg Medical showcases its silicone tubing, assemblies at CPhi & PMEC India 2021
Freudenberg Medical, a global contract manufacturer of medical device components and biopharma tubing, has showcased its premium silicone tubing, hose, and assemblies at India’s...
Dr Reddy’s partnership for Sputnik V vaccine clinical trials in India
Dr. Reddy’s Laboratories has forged a partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
Pfizer, Biontech announce vaccine candidate against Covid-19
Pfizer Inc and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against Covid-19 in participants without...
